Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer
NCT01348009
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
63
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastric Carcinoma
Interventions
DRUG:
Tesetaxel-capecitabine-cisplatin
Sponsor
Genta Incorporated